Literature DB >> 10552340

Dedifferentiation of neoplastic cells in medullary thyroid carcinoma: report of a case.

M Osaka1, J Soga, Y Tamiya, T Suzuki.   

Abstract

We report herein the unusual case of a man who was diagnosed as having sporadic medullary thyroid carcinoma (MTC) at the age of 29 years, and subsequently followed up for a period of 18 years. A total thyroidectomy with radical neck dissection was initially performed, followed by a stable interval of 16 years with regional metastases. He then developed widely disseminated metastases resulting in death within 2 years at the age of 47 years. While the neoplastic tissue from localized metastases in the soft tissue of the neck expressed strong immunohistochemical positivity to calcitonin (CT), calcitonin gene-related peptide, carcinoembryonic antigen, neuron-specific enolase, and chromogranin A during the stable interval, extremely weakened immunoreactivity to those markers was observed in samples from the disseminated metastases in the subcutaneous tissue after his clinical deterioration. Furthermore, only a few neoplastic cells in specimens obtained at postmortem sampling exhibited a weak response to CT. Ultrastructurally, the characteristic secretory granules in the neoplastic cells decreased remarkably in number, consistent with the immunohistochemical findings. These granules also diminished in diameter and intracytoplasmic small lumina and intercellular clefts with microvilli, interpreted as an attribute of anaplastic thyroid carcinomas, were frequently observed in tissues obtained after his clinical deterioration or at postmortem sampling. These cytological changes might represent dedifferentiation of the neoplastic cells or the anaplastic transformation of MTC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10552340     DOI: 10.1007/BF02482271

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  28 in total

1.  Medullary carcinoma of the thyroid. Giant cell type.

Authors:  K Kakudo; A Miyauchi; T Ogihara; S I Takai; H Kitamura; G Kosaki; Y Kumahara
Journal:  Arch Pathol Lab Med       Date:  1978-09       Impact factor: 5.534

2.  Disseminated calcitonin-poor medullary thyroid carcinoma in a patient with calcitonin-rich primary tumor.

Authors:  J M Ruppert; J C Eggleston; A deBustros; S B Baylin
Journal:  Am J Surg Pathol       Date:  1986-07       Impact factor: 6.394

3.  Transmission electron microscopy and immunocytochemistry in the diagnosis of thyroid tumors.

Authors:  M A Sobrinho-Simões; J M Nesland; R Holm; J V Johannessen
Journal:  Ultrastruct Pathol       Date:  1985       Impact factor: 1.094

4.  Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.

Authors:  M F Saad; H A Fritsche; N A Samaan
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

5.  Medullary carcinoma of the thyroid with atypical patterns.

Authors:  G Bussolati; G Monga
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

6.  Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma.

Authors:  A Miyauchi; T Onishi; S Morimoto; S Takai; F Matsuzuka; K Kuma; M Maeda; Y Kumahara
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

7.  The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase.

Authors:  S M Lippman; G Mendelsohn; D L Trump; S A Wells; S B Baylin
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

8.  Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.

Authors:  M F Saad; N G Ordonez; R K Rashid; J J Guido; C S Hill; R C Hickey; N A Samaan
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

9.  Medullary differentiation of anaplastic thyroid carcinoma.

Authors:  A C Nieuwenhuijzen Kruseman; F T Bosman; J C van Bergen Henegouw; G Cramer-Knijnenburg; G Brutel de la Riviere
Journal:  Am J Clin Pathol       Date:  1982-05       Impact factor: 2.493

10.  Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study.

Authors:  G Mendelsohn; S B Baylin; S H Bigner; S A Wells; J C Eggleston
Journal:  Am J Surg Pathol       Date:  1980-08       Impact factor: 6.394

View more
  3 in total

Review 1.  Calcitonin as a biomarker of C cell disease: recent achievements and current challenges.

Authors:  Giuseppe Costante; Domenico Meringolo
Journal:  Endocrine       Date:  2020-01-10       Impact factor: 3.633

Review 2.  Amphicrine Medullary Thyroid Carcinoma - a Case-Based Review Expanding on Its MUC Expression Profile.

Authors:  Hena Khandakar; Shipra Agarwal; Mehar Chand Sharma; Devasenathipathy Kandasamy; Chandrasekhar Bal; Yashvant Rathode; Rijuta Aphale
Journal:  Endocr Pathol       Date:  2022-06-23       Impact factor: 4.056

3.  Follicular thyroid carcinoma presenting as a massive chest wall tumor.

Authors:  Ryan Gertz; Rakesh Sarda; Ricardo Lloyd
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.